


Ask a doctor about a prescription for Vellbutrin Xr
Bupropion hydrochloride
Wellbutrin XR and Elontril are different trade names for the same medicine.
Wellbutrin XR is a prescription-only medicine used to treat depression. It works with
chemical substances in the brain called norepinephrineand dopamine.
If any of the above situations apply to you, you should contact your doctor immediately and not take Wellbutrin XR.
Before starting to take Wellbutrin XR, you should discuss it with your doctor or pharmacist.
Wellbutrin XR is not recommended for children under 18 years of age.
In children under 18 years of age treated with antidepressants, there is an increased risk of
suicidal thoughts and behaviors.
Wellbutrin XR may cause seizures in about 1 in 1000 patients. The occurrence of this side effect is more likely in patients with the conditions listed above. If seizures occur during treatment, you should stop taking Wellbutrin XR and not take it again and contact your doctor.
You should not take more of this medicine and you should contact your doctor.
In patients with depression, suicidal thoughts or behaviors may sometimes occur. Such behaviors may worsen when the patient first starts taking antidepressants, as it takes some time, usually about two weeks, but sometimes longer, for these medicines to start working.
Such thoughts may occur more frequently:
It may be helpful to inform a relative or friendthat you have depression, and ask them to read this leaflet. You may ask them to tell you if they think your depression is getting worse or if they are worried about changes in your behavior.
If you are currently taking or have taken monoamine oxidase inhibitors (MAOIs)in the last 14 days, you should contact your doctor before taking Wellbutrin XR (see also When not to take Wellbutrin XRin section 2).
You should tell your doctor or pharmacist about all medicines you are taking now or
recently, and about any medicines you plan to take,including herbal medicines or vitamins, including those available without a prescription. Your doctor may change the dose of Wellbutrin XR, recommend a change in dosage, or stop taking other medicines.
Some medicines cannot be taken with Wellbutrin XR.Some of them may increase the risk of seizures or convulsions. Other medicines may increase the risk of other side effects. Examples of such medicines are listed below, but this is not a complete list.
If any of the above situations apply to you, you should contact your doctor immediately before starting to take Wellbutrin XR. Your doctor will assess the risk and benefits of taking Wellbutrin XR.
If any of the above situations apply to you, you should contact your doctor immediately before starting to take Wellbutrin XR.
If this situation applies to you, you should inform your doctor. Your doctor will assess the effectiveness of Wellbutrin XR in you. It may be necessary to increase the dose or change the treatment of depression. You should not increasethe dose of Wellbutrin XR without your doctor's recommendation, as this may increase the risk of side effects, including seizures.
If this situation applies to you,you should tell your doctor. It may be necessary to change the treatment of depression.
If this situation applies to you,you should tell your doctor. Your doctor may consider adjusting the dose of digoxin.
Alcohol may affect the action of Wellbutrin XR, and taking them together may, although rarely, cause nervousness or changes in mental state. Some patients become more sensitive to alcohol while taking Wellbutrin XR. Your doctor may recommend avoiding alcohol (beer, wine, spirits) or significantly reducing its consumption while taking Wellbutrin XR. If you are currently drinking large amounts of alcohol, you should not stop drinking suddenly, as this may cause a seizure.
You should discuss drinking alcohol with your doctorbefore starting to take Wellbutrin XR.
Wellbutrin XR may affect the results of laboratory tests for the presence of other medicines. If you are undergoing such a test, you should inform your doctor or nurse that you are taking Wellbutrin XR.
If you are pregnant, think you may be pregnant, or plan to have a baby, you should not take Wellbutrin XR unless your doctor recommends it. Before taking this medicine during pregnancy, you should consult your doctor or pharmacist. Some, but not all, studies suggest an increased risk of birth defects, particularly heart defects, in children whose mothers took Wellbutrin XR. It is not known if this was caused by the use of this medicine.
The ingredients of Wellbutrin XR may pass into breast milk. Before taking Wellbutrin XR, you should consult your doctor or pharmacist.
If Wellbutrin XR causes dizziness or a feeling of emptiness in the head, you should not drive or operate machinery.
This medicine should always be taken exactly as your doctor or pharmacist has told you.Your doctor will recommend a dose that is right for you. If you are unsure, you should ask your doctor or pharmacist.
Wellbutrin XR is available in 150 mg and 300 mg doses.
Improvement in your condition may not occur until after some time.The full effect of the medicine may not be apparent until after several weeks or months. Even if you start to feel better, your doctor may recommend continuing to take Wellbutrin XR to prevent a relapse of depression.
What dose to take
Normally, the recommended dose for adults is one150 mg tablet once a day.
Your doctor may recommend increasing the dose to 300 mg once a day,if after several weeks of treatment, you do not show improvement.
The tablet is coated with a shell that slowly releases the medicine into the digestive tract. You may notice something in your stool that looks like a tablet. This is the empty shell that has been eliminated from the body.
Wellbutrin XR tablets should be swallowed whole.You should not chew, crush, or divide them – if this happens, there is a risk of overdose, due to the rapid release of the medicine into the body. This may increase the risk of side effects, including seizures.

For some patients, a dose of 150 mg once a day is sufficientthroughout the treatment period. Your doctor may recommend this dosage if you have liver or kidney disease.
How long to take the treatment
It may take weeks or monthsbefore any improvement is seen. You should regularly discuss your symptoms of depression with your doctor, so that it can be decided how long you should be treated. If you feel better, your doctor may recommend continuing to take Wellbutrin XR to prevent a relapse of depression.
Taking too many tablets may cause seizures or convulsions. Do not delay.You should contact your doctor or the nearest hospital emergency department immediately.
If you miss a dose, you should wait and take the next dose at the usual time. You should not take a double dose
to make up for a missed dose.
You should not stoptreatment with Wellbutrin XR or reduce the dose without first discussing it with your doctor.
If you have any further questions about the use of this medicine, you should ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
About 1 in 1000 patients taking Wellbutrin XR may experience seizures (convulsions). The risk of this is higher in patients who take higher doses than recommended, take certain medicines, or are at increased risk of seizures. If you are unsure, you should contact your doctor.
May affect more than 1 in 10people:
May affect up to 1 in 10people:
May affect up to 1 in 100people:
May affect up to 1 in 1000people:
May affect up to 1 in 10,000people:
Other side effects have occurred in a small number of patients, but their exact frequency is unknown:
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist.
Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, phone: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
You should not take this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.
Store in the original packaging to protect from light and moisture.
The bottle contains a small, tightly closed desiccant with activated carbon and silica gel, which helps keep the tablets dry. The desiccant should be left in the bottle.
Do not swallow it.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of the medicine is bupropion hydrochloride. Each tablet contains 300 mg of bupropion hydrochloride.
The other ingredients are:
Tablet core:
Polyvinyl alcohol
Glycerol dibehenate
Coating:
Ink:
Opacode S-1-17823
Shellac 45% (20% esterified), iron oxide black (E 172), and concentrated ammonium hydroxide.
Wellbutrin XR 300 mg tabletsare cream-white to light yellow, round, with the inscription "GS 5YZ 300" in black on one side of the tablet, the other side is smooth. The tablets are available in white, non-transparent HDPE bottles of 30 tablets.
For more detailed information, you should contact the marketing authorization holder or the parallel importer.
GlaxoSmithKline (Ireland) Limited
12 Riverwalk
Citywest Business Campus
Dublin 24, Ireland
Aspen Bad Oldesloe GmbH
Industriestrasse 32-36
23843 Bad Oldesloe, Germany
Glaxo Wellcome S.A.
Avenida de Extremadura, 3
09400 Aranda de Duero
Burgos, Spain
InPharm Sp. z o.o.
| Inner coating: | Outer coating: |
| Ethylcellulose | Polyethylene glycol 1450 |
| Povidone K 90 | Methacrylic acid and ethyl acrylate copolymer (1:1), dispersion |
| Polyethylene glycol 1450 | Silica, colloidal, anhydrous |
| Triethyl citrate |
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Marketing authorization number in the Czech Republic, the country of export:30/207/07-C
Wellbutrin XR: Austria, Belgium, Cyprus, Greece, Luxembourg, Malta, Poland, Portugal, Slovenia, Netherlands.
Wellbutrin: Italy.
Elontril: Czech Republic, Estonia, Germany, Hungary, Italy, Lithuania, Portugal, Romania, Slovakia, Spain, Netherlands.
Wellbutrin Retard: Iceland, Norway.
Voxra: Finland, Sweden.
Date of leaflet approval: 23.06.2022
[Information about the trademark]
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Vellbutrin Xr – subject to medical assessment and local rules.